The Pharmacokinetics of Silymarin Is Altered in Patients with Hepatitis C Virus and Nonalcoholic Fatty Liver Disease and Correlates with Plasma Caspase-3/7 Activity
2008 ◽
Vol 36
(9)
◽
pp. 1909-1916
◽
2018 ◽
Vol 57
(8)
◽
pp. 1065-1070
◽
2010 ◽
Vol 8
(1)
◽
pp. 97
◽
2016 ◽
Vol 17
(9)
◽
pp. 1545
◽
2019 ◽
Vol 31
(5)
◽
pp. 633-641
◽
2008 ◽
Vol 27
(10)
◽
pp. 855-865
◽
2003 ◽
Vol 98
(9)
◽
pp. 2064-2071
◽
2015 ◽
Vol 110
◽
pp. S854-S855